Suzanne M de la Monte Selected Research

Suzanne M de la Monte Research Topics

Disease

45	Insulin Resistance 01/2023 - 02/2005
36	Alzheimer Disease (Alzheimer's Disease) 08/2023 - 01/2002
21	Inflammation (Inflammations) 01/2023 - 08/2008
16	Cognitive Dysfunction 08/2023 - 12/2005
14	Fatty Liver 01/2022 - 01/2009
13	Fetal Alcohol Spectrum Disorders 04/2023 - 06/2007
13	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 06/2003
10	Neoplasms (Cancer) 04/2022 - 07/2002
8	Type 2 Diabetes Mellitus (MODY) 01/2012 - 09/2008
7	Neuroinflammatory Diseases 08/2023 - 01/2012
7	Obesity 01/2023 - 09/2008
6	Diabetes Mellitus 01/2023 - 02/2005
6	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2022 - 08/2007
6	Atrophy 12/2017 - 01/2012
6	Alcoholism (Alcohol Abuse) 05/2016 - 09/2008
5	Dementia (Dementias) 04/2022 - 01/2002
5	Hepatocellular Carcinoma (Hepatoma) 09/2015 - 05/2006
4	Metabolic Diseases (Metabolic Disease) 01/2016 - 01/2012
4	Alcoholic Fatty Liver 08/2011 - 01/2009
4	Carcinoma (Carcinomatosis) 05/2009 - 07/2002
3	Gliosis 01/2019 - 03/2006
3	Parkinson Disease (Parkinson's Disease) 01/2019 - 01/2009
3	Hypoxia (Hypoxemia) 12/2016 - 09/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2012 - 11/2008
3	Muscular Diseases (Myopathy) 01/2012 - 08/2007
3	Cholangiocarcinoma 01/2007 - 05/2003
2	Peripheral Nervous System Diseases (PNS Diseases) 04/2022 - 01/2012
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 04/2022 - 02/2005
2	Long Term Adverse Effects 01/2022 - 01/2016
2	Infections 01/2021 - 02/2003
2	Brain Injuries (Brain Injury) 01/2020 - 07/2019
2	Non-alcoholic Fatty Liver Disease 01/2018 - 04/2012
2	Fibrosis (Cirrhosis) 01/2013 - 01/2010
2	Spontaneous Abortion (Miscarriage) 03/2010 - 01/2007
2	Adenocarcinoma 05/2009 - 07/2002
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2007 - 07/2002
2	Neuroblastoma 12/2006 - 07/2002
1	Central Nervous System Diseases (CNS Diseases) 06/2023
1	Chronic Disease (Chronic Diseases) 04/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2022
1	Congenital Abnormalities (Deformity) 04/2022

Drug/Important Bio-Agent (IBA)

56	Insulin (Novolin)FDA Link 01/2023 - 02/2005
26	Ethanol (Ethyl Alcohol)IBA 04/2023 - 06/2007
24	Insulin-Like PeptidesIBA 01/2023 - 02/2005
19	CeramidesIBA 02/2014 - 01/2009
17	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2002
16	LipidsIBA 01/2022 - 01/2009
14	NitrosaminesIBA 01/2020 - 01/2009
11	aspartic acid 2-oxoglutarate-dependent dioxygenaseIBA 09/2010 - 07/2002
9	CytokinesIBA 08/2023 - 01/2009
9	Mixed Function Oxygenases (Monooxygenases)IBA 01/2017 - 08/2006
8	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2002
8	Streptozocin (Streptozotocin)FDA Link 12/2019 - 02/2005
8	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2010 - 12/2005
7	Insulin ReceptorIBA 01/2017 - 02/2005
6	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 12/2005
6	UbiquitinIBA 01/2019 - 06/2003
6	SmokeIBA 07/2016 - 01/2016
5	Amyloid beta-PeptidesIBA 01/2017 - 02/2005
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016 - 01/2010
5	Insulin-Like Growth Factor I (IGF-1)IBA 01/2010 - 02/2005
4	Messenger RNA (mRNA)IBA 01/2021 - 05/2006
4	Nicotine FDA Link 01/2016 - 03/2015
4	KetonesIBA 01/2016 - 03/2015
3	thermozymocidin (myriocin)IBA 01/2022 - 10/2013
3	Amyloid (Amyloid Fibrils)IBA 01/2012 - 04/2007
3	Therapeutic UsesIBA 01/2012 - 01/2009
3	Insulin-Like Growth Factor II (Somatomedin A)IBA 12/2011 - 02/2005
2	ChemokinesIBA 08/2023 - 01/2018
2	Agent OrangeIBA 01/2023 - 04/2022
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 12/2017
2	ApolipoproteinsIBA 11/2020 - 12/2019
2	Jagged-1 ProteinIBA 01/2017 - 09/2010
2	Aspartic Acid (Aspartate)FDA Link 12/2016 - 01/2016
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2016 - 01/2016
2	GhrelinIBA 05/2016 - 11/2014
2	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 01/2016 - 09/2008
2	3-nitrotyrosineIBA 11/2015 - 06/2012
2	Transcription Factors (Transcription Factor)IBA 11/2015 - 09/2010
2	AcetylcholinesteraseIBA 11/2015 - 01/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2013 - 12/2006
2	Glycogen Synthase KinasesIBA 01/2013 - 03/2006
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 04/2012 - 12/2011
2	Neurotransmitter Agents (Neurotransmitter)IBA 03/2012 - 03/2011
2	Triglycerides (Triacylglycerol)IBA 12/2011 - 01/2009
2	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 04/2011 - 01/2010
2	RNA (Ribonucleic Acid)IBA 03/2011 - 01/2007
2	Glycoproteins (Glycoprotein)IBA 01/2010 - 12/2003
2	Glycogen Synthase Kinase 3 betaIBA 06/2009 - 09/2008
2	Monoclonal AntibodiesIBA 05/2009 - 07/2002
2	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 01/2009 - 06/2003
2	AD7c-NTPIBA 06/2004 - 01/2002
1	Choline (Choline Chloride)IBA 04/2023
1	IsoflavonesIBA 04/2023
1	Sirolimus (Rapamycin)FDA Link 01/2023
1	2,4-Dichlorophenoxyacetic Acid (2,4 Dichlorophenoxyacetic Acid)IBA 01/2023
1	2,4,5-Trichlorophenoxyacetic Acid (2,4,5-T)IBA 01/2023

Therapy/Procedure

9	Therapeutics 01/2023 - 01/2009
1	Lasers (Laser) 06/2023
1	General Anesthesia 01/2023